NADOX

Serial Number 99495796
630

Registration Progress

Application Filed
Nov 13, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

NADOX

Basic Information

Serial Number
99495796
Filing Date
November 13, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
630
Status Date
Nov 13, 2025
Application
Pending
Classes
005

Rights Holder

PharmaResearch Co., Ltd.

99
Address
77-19, Gwahakdanji-ro, Gangwon-do
Gangneung-si 25452
KR

Ownership History

PharmaResearch Co., Ltd.

Original Applicant
99
Gangneung-si KR

Legal Representation

Attorney
John M. Kim

Application History

3 events
Date Code Type Description Documents
Nov 13, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 13, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antibiotic preparations relating to doxorubicin; chemotherapeutics relating to doxorubicin; pharmaceutical preparations for the treatment of tumours relating to doxorubicin; pharmaceutical preparations for chemical disorder treatment relating to doxorubicin; pharmaceutical agents affecting sensory organs relating to doxorubicin; pharmaceutical agents affecting metabolism relating to doxorubicin; pharmaceutical agents affecting peripheral nervous system relating to doxorubicin; cardiovascular pharmaceutical preparations relating to doxorubicin; pharmaceutical preparations and compositions for the treatment and prevention of cancer relating to doxorubicin; pharmaceutical preparations and substances for the prevention of cancer relating to doxorubicin; biopharmaceuticals for the treatment of cancer relating to doxorubicin; biological preparations for the treatment of cancer relating to doxorubicin; pharmaceutical preparations for the treatment of cancer relating to doxorubicin; compounds for treating cancer relating to doxorubicin; pharmaceutical preparations acting on the central nervous system relating to doxorubicin; analgesic preparations relating to doxorubicin; antibiotics relating to doxorubicin; pharmaceutical preparations for respiratory organs relating to doxorubicin; anti-cancer preparations relating to doxorubicin

Classification

International Classes
005